Regulus Therapeutics Inc (RGLS)
2.24
+0.02
(+0.90%)
USD |
NASDAQ |
Apr 25, 12:32
Regulus Therapeutics Profit Margin (Quarterly)
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | -26.44% |
| September 30, 2020 | -30.48% |
| June 30, 2020 | |
| March 31, 2020 | -98.95K% |
| December 31, 2019 | -27.18K% |
| September 30, 2019 | -30.13K% |
| June 30, 2019 | -27.87K% |
| March 31, 2019 | -48.10% |
| December 31, 2018 | -47.57K% |
| September 30, 2018 | -57.07K% |
| June 30, 2018 | -76.93K% |
| March 31, 2018 | -89.03K% |
| December 31, 2017 | -80.27K% |
| September 30, 2017 | -87.93K% |
| June 30, 2017 | -120.0K% |
| March 31, 2017 | -111.2K% |
| December 31, 2016 | -111.2K% |
| September 30, 2016 | -9.57K% |
| June 30, 2016 | -4.37K% |
| Date | Value |
|---|---|
| March 31, 2016 | -4.34K% |
| December 31, 2015 | -66.54% |
| September 30, 2015 | -697.1% |
| June 30, 2015 | -548.6% |
| March 31, 2015 | -344.9% |
| December 31, 2014 | -525.4% |
| September 30, 2014 | -904.7% |
| June 30, 2014 | -1.63K% |
| March 31, 2014 | -781.2% |
| December 31, 2013 | -35.33% |
| September 30, 2013 | -35.37% |
| June 30, 2013 | -154.4% |
| March 31, 2013 | -223.3% |
| December 31, 2012 | -212.4% |
| September 30, 2012 | -202.4% |
| June 30, 2012 | -78.54% |
| March 31, 2012 | -67.20% |
| December 31, 2011 | -59.92% |
| September 30, 2011 | -27.44% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-98.95K%
Minimum
Mar 2020
-26.44%
Maximum
Dec 2020
-30.70K%
Average
-27.52K%
Median
Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals Inc | 19.82% |
| ADMA Biologics Inc | -23.88% |
| FibroGen Inc | -207.2% |
| Protara Therapeutics Inc | -- |
| Amylyx Pharmaceuticals Inc | 4.36% |